CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies amend existing drug discovery partnership for Evotec to lead continued...